KEGG   PATHWAY: ggo05200
Entry
ggo05200                    Pathway                                
Name
Pathways in cancer - Gorilla gorilla gorilla (western lowland gorilla)
Class
Human Diseases; Cancer: overview
Pathway map
ggo05200  Pathways in cancer
ggo05200

Organism
Gorilla gorilla gorilla (western lowland gorilla) [GN:ggo]
Gene
101123716  DLL4; delta-like protein 4 [KO:K06051]
101123790  MGST3; glutathione S-transferase 3, mitochondrial isoform X1 [KO:K00799] [EC:2.5.1.18]
101124029  CDC42; cell division control protein 42 homolog isoform X1 [KO:K04393]
101124033  MAPK8; mitogen-activated protein kinase 8 isoform X4 [KO:K04440] [EC:2.7.11.24]
101124266  [KO:K10031]
101124359  RUNX1; runt-related transcription factor 1 isoform X1 [KO:K08367]
101124427  RASSF1; ras association domain-containing protein 1 isoform X2 [KO:K09850]
101124461  MSH3; DNA mismatch repair protein Msh3 isoform X1 [KO:K08736]
101124467  CTNNA1; catenin alpha-1 isoform X2 [KO:K05691]
101124474  TGFB1; transforming growth factor beta-1 proprotein isoform X2 [KO:K13375]
101124528  ZBTB16; zinc finger and BTB domain-containing protein 16 [KO:K10055]
101124609  LAMA5; laminin subunit alpha-5 isoform X1 [KO:K06240]
101124698  KIF7; kinesin-like protein KIF7 isoform X4 [KO:K18806]
101124828  PRKCA; protein kinase C alpha type isoform X1 [KO:K02677] [EC:2.7.11.13]
101124898  [KO:K03873]
101124928  PDGFRA; platelet-derived growth factor receptor alpha isoform X2 [KO:K04363] [EC:2.7.10.1]
101124934  IL4R; interleukin-4 receptor subunit alpha isoform X6 [KO:K05071]
101125053  PGF; placenta growth factor isoform X1 [KO:K16859]
101125404  KITLG; kit ligand isoform X1 [KO:K05461]
101125453  BBC3; bcl-2-binding component 3 isoform X2 [KO:K10132]
101125504  TGFB2; transforming growth factor beta-2 proprotein isoform X2 [KO:K13376]
101125534  GSK3B; glycogen synthase kinase-3 beta isoform X2 [KO:K03083] [EC:2.7.11.26]
101125616  GNAI3; guanine nucleotide-binding protein G(I) subunit alpha-3 [KO:K04630]
101125817  DAPK3; death-associated protein kinase 3 [KO:K08803] [EC:2.7.11.1]
101125849  IL15RA; interleukin-15 receptor subunit alpha isoform X3 [KO:K05074]
101125864  RASGRP2; RAS guanyl-releasing protein 2 isoform X2 [KO:K12361]
101125890  ADCY4; adenylate cyclase type 4 isoform X6 [KO:K08044] [EC:4.6.1.1]
101125943  ADCY1; adenylate cyclase type 1 isoform X1 [KO:K08041] [EC:4.6.1.1]
101125987  [KO:K03872]
101125993  NTRK1; high affinity nerve growth factor receptor isoform X2 [KO:K03176] [EC:2.7.10.1]
101126138  BMP4; bone morphogenetic protein 4 isoform X2 [KO:K04662]
101126190  EGFR; epidermal growth factor receptor isoform X1 [KO:K04361] [EC:2.7.10.1]
101126210  IL2RA; interleukin-2 receptor subunit alpha [KO:K05068]
101126268  ADCY7; adenylate cyclase type 7 isoform X1 [KO:K08047] [EC:4.6.1.1]
101126364  LPAR5; lysophosphatidic acid receptor 5 [KO:K08390]
101126389  KIT; mast/stem cell growth factor receptor Kit isoform X7 [KO:K05091] [EC:2.7.10.1]
101126422  DLL3; delta-like protein 3 isoform X3 [KO:K06051]
101126528  LPAR2; lysophosphatidic acid receptor 2 [KO:K04291]
101126536  FZD1; frizzled-1 [KO:K02432]
101126640  CDKN1A; cyclin-dependent kinase inhibitor 1 isoform X1 [KO:K06625]
101126719  BRCA2; breast cancer type 2 susceptibility protein isoform X1 [KO:K08775]
101126724  APPL1; DCC-interacting protein 13-alpha isoform X1 [KO:K08733]
101126742  CASP3; caspase-3 isoform X1 [KO:K02187] [EC:3.4.22.56]
101126746  RPS6KB1; ribosomal protein S6 kinase beta-1 isoform X1 [KO:K04688] [EC:2.7.11.1]
101126795  TRAF1; TNF receptor-associated factor 1 [KO:K03172]
101126805  FGF8; fibroblast growth factor 8 isoform X1 [KO:K04358]
101126885  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
101126938  BIRC3; baculoviral IAP repeat-containing protein 3 [KO:K16060]
101127012  [KO:K04725] [EC:2.3.2.27]
101127150  ELOC; elongin-C isoform X1 [KO:K03872]
101127165  ABL1; tyrosine-protein kinase ABL1 isoform X3 [KO:K06619] [EC:2.7.10.2]
101127372  ITGA2; integrin alpha-2 [KO:K06481]
101127399  MET; hepatocyte growth factor receptor isoform X2 [KO:K05099] [EC:2.7.10.1]
101127403  CRKL; crk-like protein [KO:K04438]
101127444  FH; fumarate hydratase, mitochondrial [KO:K01679] [EC:4.2.1.2]
101127551  GSTM2; glutathione S-transferase Mu 2 [KO:K00799] [EC:2.5.1.18]
101127590  FOS; protein C-Fos [KO:K04379]
101127646  [KO:K02219]
101127672  LRP5; low-density lipoprotein receptor-related protein 5 [KO:K03068]
101127675  BIRC2; baculoviral IAP repeat-containing protein 2 [KO:K16060]
101127820  HSP90B1; endoplasmin [KO:K09487]
101127877  HGF; hepatocyte growth factor isoform X1 [KO:K05460]
101128036  DDB2; DNA damage-binding protein 2 isoform X1 [KO:K10140]
101128055  RARB; retinoic acid receptor beta isoform X2 [KO:K08528]
101128130  SMO; protein smoothened isoform X1 [KO:K06226]
101128153  LAMC3; laminin subunit gamma-3 [KO:K06247]
101128172  RASSF5; ras association domain-containing protein 5 isoform X2 [KO:K08015]
101128204  NFKBIA; NF-kappa-B inhibitor alpha [KO:K04734]
101128291  VEGFB; vascular endothelial growth factor B isoform X1 [KO:K16858]
101128311  COL4A1; collagen alpha-1(IV) chain isoform X1 [KO:K06237]
101128323  ARNT2; aryl hydrocarbon receptor nuclear translocator 2 isoform X1 [KO:K15589]
101128395  GSTM4; glutathione S-transferase Mu 4 [KO:K00799] [EC:2.5.1.18]
101128400  ARHGEF11; rho guanine nucleotide exchange factor 11 isoform X10 [KO:K12331]
101128423  FGF9; fibroblast growth factor 9 [KO:K04358]
101128433  AGTR1; type-1 angiotensin II receptor [KO:K04166]
101128510  TGFBR1; TGF-beta receptor type-1 isoform X2 [KO:K04674] [EC:2.7.11.30]
101128620  PTK2; focal adhesion kinase 1 isoform X14 [KO:K05725] [EC:2.7.10.2]
101128749  RXRA; retinoic acid receptor RXR-alpha isoform X1 [KO:K08524]
101128750  CSF3R; granulocyte colony-stimulating factor receptor [KO:K05061]
101128753  GSTM3; glutathione S-transferase Mu 3 [KO:K00799] [EC:2.5.1.18]
101128843  [KO:K04393]
101128930  [KO:K11224]
101128994  WNT11; protein Wnt-11 [KO:K01384]
101129045  DCC; netrin receptor DCC isoform X1 [KO:K06765]
101129138  FGF7; fibroblast growth factor 7 isoform X1 [KO:K04358]
101129159  TERT; telomerase reverse transcriptase isoform X1 [KO:K11126] [EC:2.7.7.49]
101129170  [KO:K08738]
101129307  JAG1; protein jagged-1 [KO:K06052]
101129331  CKS2; cyclin-dependent kinases regulatory subunit 2 [KO:K02219]
101129336  PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma isoform X2 [KO:K02649]
101129341  GSTM1; glutathione S-transferase Mu 1 [KO:K00799] [EC:2.5.1.18]
101129357  PLCB3; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 isoform X1 [KO:K05858] [EC:3.1.4.11]
101129430  HEY2; hairy/enhancer-of-split related with YRPW motif protein 2 isoform X1 [KO:K09091]
101129671  GNA11; guanine nucleotide-binding protein subunit alpha-11 [KO:K04635]
101129792  CEBPA; CCAAT/enhancer-binding protein alpha [KO:K09055]
101129803  STK4; serine/threonine-protein kinase 4 isoform X1 [KO:K04411]
101129834  WNT2B; protein Wnt-2b [KO:K00182]
101129964  MDM2; E3 ubiquitin-protein ligase Mdm2 isoform X3 [KO:K06643] [EC:2.3.2.27]
101130056  PTGER3; prostaglandin E2 receptor EP3 subtype isoform X2 [KO:K04260]
101130129  APC2; adenomatous polyposis coli protein 2 isoform X1 [KO:K02085]
101130228  CCNA2; cyclin-A2 [KO:K06627]
101130311  IL6R; interleukin-6 receptor subunit alpha isoform X1 [KO:K05055]
101130379  FLT4; vascular endothelial growth factor receptor 3 isoform X1 [KO:K05097] [EC:2.7.10.1]
101130414  CASP9; caspase-9 isoform X1 [KO:K04399] [EC:3.4.22.62]
101130440  TRAF5; TNF receptor-associated factor 5 isoform X2 [KO:K09849]
101130447  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
101130552  GSTM5; glutathione S-transferase Mu 5 [KO:K00799] [EC:2.5.1.18]
101130575  STAT6; signal transducer and activator of transcription 6 isoform X4 [KO:K11225]
101130628  CCND3; G1/S-specific cyclin-D3 isoform X1 [KO:K10152]
101130732  CXCL8; interleukin-8 [KO:K10030]
101130779  WNT2; protein Wnt-2 [KO:K00182]
101130790  COL4A6; collagen alpha-6(IV) chain isoform X6 [KO:K06237]
101130824  SOS1; son of sevenless homolog 1 isoform X1 [KO:K03099]
101130978  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X2 [KO:K02649]
101131033  NFKB2; nuclear factor NF-kappa-B p100 subunit isoform X1 [KO:K04469]
101131042  SPI1; transcription factor PU.1 isoform X2 [KO:K09438]
101131051  MMP1; interstitial collagenase [KO:K01388] [EC:3.4.24.7]
101131073  LAMB2; laminin subunit beta-2 isoform X1 [KO:K06243]
101131137  FGF17; fibroblast growth factor 17 isoform X1 [KO:K04358]
101131502  RUNX1T1; protein CBFA2T1 isoform X3 [KO:K10053]
101131508  GADD45G; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
101131770  STAT1; signal transducer and activator of transcription 1-alpha/beta isoform X3 [KO:K11220]
101131781  FLT3; receptor-type tyrosine-protein kinase FLT3 [KO:K05092] [EC:2.7.10.1]
101131912  BDKRB1; B1 bradykinin receptor [KO:K03915]
101131949  VEGFA; vascular endothelial growth factor A, long form isoform X3 [KO:K05448]
101131951  ARHGEF1; rho guanine nucleotide exchange factor 1 isoform X1 [KO:K12330]
101132059  PDGFA; platelet-derived growth factor subunit A isoform X1 [KO:K04359]
101132139  LPAR6; lysophosphatidic acid receptor 6 isoform X1 [KO:K04273]
101132154  JAG2; protein jagged-2 isoform X1 [KO:K21635]
101132215  [KO:K04632]
101132221  [KO:K00799] [EC:2.5.1.18]
101132251  LAMC1; laminin subunit gamma-1 [KO:K05635]
101132362  RALB; ras-related protein Ral-B isoform X2 [KO:K07835]
101132391  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
101132394  IL2; interleukin-2 [KO:K05429]
101132496  WNT6; protein Wnt-6 isoform X2 [KO:K00445]
101132514  BDKRB2; B2 bradykinin receptor isoform X1 [KO:K03916]
101132608  LAMC2; laminin subunit gamma-2 [KO:K06246]
101132761  RASGRP1; RAS guanyl-releasing protein 1 [KO:K04350]
101132851  FGF4; fibroblast growth factor 4 [KO:K04358]
101132868  WNT10A; protein Wnt-10a [KO:K01357]
101132913  IL3; interleukin-3 [KO:K04736]
101132916  LAMA3; laminin subunit alpha-3 isoform X2 [KO:K06240]
101133120  TXNRD1; thioredoxin reductase 1, cytoplasmic isoform X9 [KO:K22182] [EC:1.8.1.9]
101133141  MAPK10; mitogen-activated protein kinase 10 isoform X1 [KO:K04440] [EC:2.7.11.24]
101133147  GNG13; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13 [KO:K04547]
101133237  RB1; retinoblastoma-associated protein isoform X1 [KO:K06618]
101133265  WNT3; proto-oncogene Wnt-3 isoform X1 [KO:K00312]
101133308  ELK1; ETS domain-containing protein Elk-1 isoform X2 [KO:K04375]
101133331  JAK1; tyrosine-protein kinase JAK1 isoform X1 [KO:K11217] [EC:2.7.10.2]
101133471  IGF2; insulin-like growth factor II isoform X2 [KO:K13769]
101133524  TP53; cellular tumor antigen p53 isoform X2 [KO:K04451]
101133569  ZBTB17; zinc finger and BTB domain-containing protein 17 isoform X2 [KO:K10500]
101133590  FGF3; fibroblast growth factor 3 [KO:K04358]
101133643  PLCG2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 isoform X1 [KO:K05859] [EC:3.1.4.11]
101133658  PIM1; serine/threonine-protein kinase pim-1 [KO:K04702] [EC:2.7.11.1]
101133741  TGFB3; transforming growth factor beta-3 proprotein [KO:K13377]
101133803  IL13RA1; interleukin-13 receptor subunit alpha-1 isoform X1 [KO:K05076]
101133804  XIAP; E3 ubiquitin-protein ligase XIAP [KO:K04725] [EC:2.3.2.27]
101133910  COL4A5; collagen alpha-5(IV) chain [KO:K06237]
101133942  GLI2; zinc finger protein GLI2 isoform X2 [KO:K16798]
101133976  GRB2; growth factor receptor-bound protein 2 [KO:K04364]
101133994  F2RL3; proteinase-activated receptor 4 [KO:K04236]
101134077  PPARG; peroxisome proliferator-activated receptor gamma isoform X1 [KO:K08530]
101134088  CTBP1; C-terminal-binding protein 1 isoform X3 [KO:K04496] [EC:1.1.1.428]
101134101  WNT9B; protein Wnt-9b isoform X1 [KO:K01064]
101134136  LAMB1; laminin subunit beta-1 [KO:K05636]
101134260  PRKACB; cAMP-dependent protein kinase catalytic subunit beta isoform X1 [KO:K04345] [EC:2.7.11.11]
101134274  FADD; FAS-associated death domain protein [KO:K02373]
101134343  NOTCH3; neurogenic locus notch homolog protein 3 isoform X1 [KO:K20995]
101134372  FZD6; frizzled-6 [KO:K02376]
101134461  SKP2; S-phase kinase-associated protein 2 isoform X1 [KO:K03875]
101134470  CCNE1; G1/S-specific cyclin-E1 isoform X1 [KO:K06626]
101134487  LAMB4; laminin subunit beta-4 isoform X1 [KO:K06245]
101134493  ARAF; serine/threonine-protein kinase A-Raf isoform X2 [KO:K08845] [EC:2.7.11.1]
101134525  RPS6KB2; ribosomal protein S6 kinase beta-2 [KO:K04688] [EC:2.7.11.1]
101134530  GNB3; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3 isoform X1 [KO:K07825]
101134554  EDNRA; endothelin-1 receptor isoform X1 [KO:K04197]
101134560  GNGT2; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2 [KO:K04549]
101134676  CAMK2D; calcium/calmodulin-dependent protein kinase type II subunit delta isoform X28 [KO:K04515] [EC:2.7.11.17]
101134686  [KO:K11223]
101134711  BIRC7; baculoviral IAP repeat-containing protein 7 [KO:K16061]
101134769  CDK2; cyclin-dependent kinase 2 isoform X1 [KO:K02206] [EC:2.7.11.22]
101134778  RHOA; transforming protein RhoA [KO:K04513]
101134891  MLH1; DNA mismatch repair protein Mlh1 isoform X1 [KO:K08734]
101134923  NOS2; nitric oxide synthase, inducible isoform X1 [KO:K13241] [EC:1.14.13.39]
101134933  IL12RB1; interleukin-12 receptor subunit beta-1 isoform X1 [KO:K05063]
101134974  CCDC6; coiled-coil domain-containing protein 6 [KO:K09288]
101134988  ROCK2; rho-associated protein kinase 2 isoform X1 [KO:K17388] [EC:2.7.11.1]
101135016  MITF; microphthalmia-associated transcription factor isoform X2 [KO:K09455]
101135038  STAT3; signal transducer and activator of transcription 3 isoform X1 [KO:K04692]
101135135  [KO:K07834]
101135150  PLD1; phospholipase D1 isoform X1 [KO:K01115] [EC:3.1.4.4]
101135199  PLCG1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X1 [KO:K01116] [EC:3.1.4.11]
101135298  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
101135430  RAC1; ras-related C3 botulinum toxin substrate 1 isoform X3 [KO:K04392]
101135431  [KO:K08738]
101135528  FGF10; fibroblast growth factor 10 [KO:K04358]
101135722  APAF1; apoptotic protease-activating factor 1 isoform X1 [KO:K02084]
101135749  FGF5; fibroblast growth factor 5 isoform X1 [KO:K04358]
101135754  [KO:K09290]
101135794  BCR; breakpoint cluster region protein isoform X1 [KO:K08878] [EC:2.7.11.1]
101135988  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
101135996  PLD2; phospholipase D2 isoform X1 [KO:K01115] [EC:3.1.4.4]
101136113  ITGA2B; integrin alpha-IIb [KO:K06476]
101136123  BCL2; apoptosis regulator Bcl-2 [KO:K02161]
101136145  NCOA3; nuclear receptor coactivator 3 isoform X2 [KO:K11256] [EC:2.3.1.48]
101136283  CSF2RB; cytokine receptor common subunit beta isoform X1 [KO:K04738]
101136311  NCOA4; nuclear receptor coactivator 4 isoform X2 [KO:K09289]
101136350  HIF1A; hypoxia-inducible factor 1-alpha isoform X1 [KO:K08268]
101136425  HRAS; GTPase HRas isoform X1 [KO:K02833]
101136454  RAF1; RAF proto-oncogene serine/threonine-protein kinase isoform X3 [KO:K04366] [EC:2.7.11.1]
101136457  CCNA1; cyclin-A1 isoform X1 [KO:K06627]
101136547  CAMK2G; calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X1 [KO:K04515] [EC:2.7.11.17]
101136595  TRAF3; TNF receptor-associated factor 3 isoform X1 [KO:K03174]
101136716  FZD2; frizzled-2 [KO:K02235]
101136942  COL4A4; collagen alpha-4(IV) chain [KO:K06237]
101137026  MYC; myc proto-oncogene protein [KO:K04377]
101137064  STAT4; signal transducer and activator of transcription 4 [KO:K11222]
101137098  APC; adenomatous polyposis coli protein isoform X7 [KO:K02085]
101137174  PAX8; paired box protein Pax-8 isoform X1 [KO:K09293]
101137199  MGST2; microsomal glutathione S-transferase 2 isoform X1 [KO:K00799] [EC:2.5.1.18]
101137223  FGF22; fibroblast growth factor 22 isoform X2 [KO:K04358]
101137227  PTGER1; prostaglandin E2 receptor EP1 subtype [KO:K04258]
101137308  COL4A3; collagen alpha-3(IV) chain isoform X1 [KO:K06237]
101137337  FGF2; fibroblast growth factor 2 [KO:K18497]
101137405  CHUK; inhibitor of nuclear factor kappa-B kinase subunit alpha [KO:K04467] [EC:2.7.11.10]
101137539  SOS2; son of sevenless homolog 2 isoform X2 [KO:K03099]
101137568  POLK; DNA polymerase kappa isoform X3 [KO:K03511] [EC:2.7.7.7]
101137595  E2F1; transcription factor E2F1 [KO:K17454]
101137662  CXCR4; C-X-C chemokine receptor type 4 isoform X3 [KO:K04189]
101137723  AKT2; RAC-beta serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
101137781  FASLG; tumor necrosis factor ligand superfamily member 6 [KO:K04389]
101137870  IFNA21; interferon alpha-21 [KO:K05414]
101137927  HES1; transcription factor HES-1 [KO:K06054]
101138019  AKT3; RAC-gamma serine/threonine-protein kinase isoform X2 [KO:K04456] [EC:2.7.11.1]
101138168  FN1; fibronectin isoform X2 [KO:K05717]
101138211  E2F3; transcription factor E2F3 isoform X3 [KO:K06620]
101138361  MMP9; matrix metalloproteinase-9 [KO:K01403] [EC:3.4.24.35]
101138372  IL7; interleukin-7 isoform X1 [KO:K05431]
101138467  IL5; interleukin-5 [KO:K05428]
101138492  PDGFB; platelet-derived growth factor subunit B [KO:K17386]
101138554  KNG1; kininogen-1 isoform X1 [KO:K03898]
101138588  [KO:K00799] [EC:2.5.1.18]
101138602  WNT16; protein Wnt-16 isoform X1 [KO:K01558]
101138640  CKS1B; cyclin-dependent kinases regulatory subunit 1 [KO:K02219]
101138742  GNG5; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 isoform X2 [KO:K04542]
101138779  CTNNB1; catenin beta-1 isoform X1 [KO:K02105]
101138898  CASP8; caspase-8 isoform X1 [KO:K04398] [EC:3.4.22.61]
101138953  ESR1; estrogen receptor isoform X1 [KO:K08550]
101138981  [KO:K05414]
101138988  PTCH1; protein patched homolog 1 isoform X1 [KO:K06225]
101138990  MTOR; serine/threonine-protein kinase mTOR [KO:K07203] [EC:2.7.11.1]
101139013  CALM2; calmodulin-2 isoform X1 [KO:K02183]
101139020  GLI1; zinc finger protein GLI1 isoform X1 [KO:K16797]
101139074  PRKCG; protein kinase C gamma type [KO:K19663] [EC:2.7.11.13]
101139192  IL13; interleukin-13 isoform X1 [KO:K05435]
101139212  GNGT1; guanine nucleotide-binding protein G(T) subunit gamma-T1 [KO:K04548]
101139336  [KO:K05414]
101139397  CALML4; calmodulin-like protein 4 isoform X1 [KO:K02183]
101139427  GNG14; LOW QUALITY PROTEIN: putative guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-14 [KO:K04347]
101139583  IL2RB; interleukin-2 receptor subunit beta [KO:K05069]
101139713  [KO:K05414]
101139722  WNT4; protein Wnt-4 [KO:K00408]
101139749  CCND2; G1/S-specific cyclin-D2 [KO:K10151]
101139873  ADCY6; adenylate cyclase type 6 isoform X1 [KO:K08046] [EC:4.6.1.1]
101139938  GNG11; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11 [KO:K04546]
101139939  GNB2; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 [KO:K04537]
101139997  FGFR3; fibroblast growth factor receptor 3 isoform X11 [KO:K05094] [EC:2.7.10.1]
101140015  IL4; interleukin-4 isoform X1 [KO:K05430]
101140025  RASGRP4; RAS guanyl-releasing protein 4 isoform X2 [KO:K12363]
101140164  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
101140168  VEGFD; vascular endothelial growth factor D [KO:K05449]
101140197  WNT8B; protein Wnt-8b [KO:K00714]
101140219  CTNNA2; catenin alpha-2 isoform X1 [KO:K05691]
101140239  TFG; protein TFG isoform X1 [KO:K09292]
101140253  LEF1; lymphoid enhancer-binding factor 1 isoform X4 [KO:K04492]
101140270  GADD45B; growth arrest and DNA damage-inducible protein GADD45 beta isoform X2 [KO:K04402]
101140325  CBL; E3 ubiquitin-protein ligase CBL [KO:K04707] [EC:2.3.2.27]
101140326  TGFA; protransforming growth factor alpha isoform X1 [KO:K08774]
101140350  PLCB2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 isoform X4 [KO:K05858] [EC:3.1.4.11]
101140372  IL7R; interleukin-7 receptor subunit alpha isoform X1 [KO:K05072]
101140412  [KO:K05414]
101140441  FGF23; fibroblast growth factor 23 [KO:K22428]
101140531  HEY1; hairy/enhancer-of-split related with YRPW motif protein 1 isoform X2 [KO:K09091]
101140627  [KO:K02183]
101140639  GNG7; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7 [KO:K04543]
101140784  IFNAR2; interferon alpha/beta receptor 2 isoform X1 [KO:K05131]
101140831  FGF6; fibroblast growth factor 6 [KO:K04358]
101140874  VEGFC; vascular endothelial growth factor C [KO:K05449]
101140885  ERBB2; receptor tyrosine-protein kinase ErbB-2 isoform X1 [KO:K05083] [EC:2.7.10.1]
101141078  AGT; angiotensinogen precursor [KO:K09821]
101141143  LAMA2; laminin subunit alpha-2 isoform X1 [KO:K05637]
101141158  IFNAR1; interferon alpha/beta receptor 1 [KO:K05130]
101141176  IFNA6; interferon alpha-6 [KO:K05414]
101141274  IL12B; interleukin-12 subunit beta [KO:K05425]
101141297  FZD9; frizzled-9 [KO:K02842]
101141352  FZD10; frizzled-10 [KO:K02842]
101141389  ADCY2; adenylate cyclase type 2 isoform X2 [KO:K08042] [EC:4.6.1.1]
101141476  TXNRD3; thioredoxin reductase 3 isoform X1 [KO:K22182] [EC:1.8.1.9]
101141508  [KO:K03872]
101141528  TXNRD2; thioredoxin reductase 2, mitochondrial isoform X5 [KO:K22182] [EC:1.8.1.9]
101141534  RAC2; ras-related C3 botulinum toxin substrate 2 isoform X1 [KO:K07860]
101141543  [KO:K05414]
101141559  RET; proto-oncogene tyrosine-protein kinase receptor Ret isoform X1 [KO:K05126] [EC:2.7.10.1]
101141580  ALK; ALK tyrosine kinase receptor [KO:K05119] [EC:2.7.10.1]
101141654  EPO; erythropoietin [KO:K05437]
101141659  IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta isoform X1 [KO:K07209] [EC:2.7.11.10]
101141693  GSTP1; glutathione S-transferase P [KO:K23790]
101141752  PPARD; peroxisome proliferator-activated receptor delta isoform X1 [KO:K04504]
101141916  IFNA2; interferon alpha-2 [KO:K05414]
101141949  GNG4; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4 [KO:K04541]
101142002  FGF18; fibroblast growth factor 18 [KO:K04358]
101142025  BCL2L1; bcl-2-like protein 1 isoform X1 [KO:K04570]
101142032  BID; BH3-interacting domain death agonist isoform X1 [KO:K04726]
101142058  LPAR3; lysophosphatidic acid receptor 3 [KO:K04294]
101142205  LRP6; low-density lipoprotein receptor-related protein 6 isoform X1 [KO:K03068]
101142301  IFNA8; interferon alpha-8 [KO:K05414]
101142445  TPR; nucleoprotein TPR [KO:K09291]
101142471  ESR2; estrogen receptor beta isoform X1 [KO:K08551]
101142672  ADCY8; adenylate cyclase type 8 isoform X1 [KO:K08048] [EC:4.6.1.1]
101142673  [KO:K05414]
101142683  ITGB1; integrin beta-1 [KO:K05719]
101142752  EDN1; endothelin-1 [KO:K16366]
101142818  WNT10B; protein Wnt-10b [KO:K01357]
101142858  TRAF4; TNF receptor-associated factor 4 [KO:K09848]
101143109  RXRB; retinoic acid receptor RXR-beta isoform X2 [KO:K08525]
101143172  NCOA1; nuclear receptor coactivator 1 isoform X1 [KO:K09101] [EC:2.3.1.48]
101143181  WNT1; proto-oncogene Wnt-1 [KO:K03209]
101143213  IL15; interleukin-15 isoform X1 [KO:K05433]
101143230  LAMA1; laminin subunit alpha-1 isoform X2 [KO:K05637]
101143444  [KO:K00799] [EC:2.5.1.18]
101143561  MECOM; histone-lysine N-methyltransferase MECOM isoform X6 [KO:K04462] [EC:2.1.1.367]
101143620  FGF20; fibroblast growth factor 20 [KO:K04358]
101143627  AR; androgen receptor isoform X1 [KO:K08557]
101143682  EDNRB; endothelin receptor type B [KO:K04198]
101143757  FZD3; frizzled-3 isoform X1 [KO:K02329]
101143774  IL23R; interleukin-23 receptor [KO:K05065]
101143811  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
101143849  HSP90AB1; heat shock protein HSP 90-beta isoform X2 [KO:K04079]
101143851  KLK3; prostate-specific antigen isoform X3 [KO:K01351] [EC:3.4.21.77]
101143886  [KO:K09487]
101144031  ADCY3; adenylate cyclase type 3 isoform X4 [KO:K08043] [EC:4.6.1.1]
101144039  KRAS; GTPase KRas isoform X2 [KO:K07827]
101144355  IFNGR2; interferon gamma receptor 2 [KO:K05133]
101144399  EML4; echinoderm microtubule-associated protein-like 4 isoform X1 [KO:K15420]
101144448  F2R; proteinase-activated receptor 1 [KO:K03914]
101144503  IL12RB2; interleukin-12 receptor subunit beta-2 isoform X1 [KO:K05064]
101144636  FZD4; frizzled-4 [KO:K02354]
101144743  RALGDS; ral guanine nucleotide dissociation stimulator isoform X3 [KO:K08732]
101144745  TRAF2; TNF receptor-associated factor 2 isoform X1 [KO:K03173] [EC:2.3.2.27]
101144808  CREBBP; CREB-binding protein isoform X2 [KO:K04498] [EC:2.3.1.48]
101144860  [KO:K04503]
101144872  LPAR1; lysophosphatidic acid receptor 1 [KO:K04289]
101144887  ARNT; aryl hydrocarbon receptor nuclear translocator isoform X1 [KO:K09097]
101144905  MGST1; microsomal glutathione S-transferase 1 isoform X3 [KO:K00799] [EC:2.5.1.18]
101145045  DVL3; segment polarity protein dishevelled homolog DVL-3 isoform X1 [KO:K02353]
101145049  GNB5; guanine nucleotide-binding protein subunit beta-5 [KO:K04539]
101145052  PML; protein PML [KO:K10054] [EC:2.3.2.-]
101145089  [KO:K09290]
101145098  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
101145130  CTBP2; C-terminal-binding protein 2 isoform X1 [KO:K04496] [EC:1.1.1.428]
101145191  CDH1; cadherin-1 [KO:K05689]
101145205  FGFR4; fibroblast growth factor receptor 4 isoform X1 [KO:K05095] [EC:2.7.10.1]
101145372  MSH2; DNA mismatch repair protein Msh2 isoform X1 [KO:K08735]
101145410  ADCY9; adenylate cyclase type 9 isoform X1 [KO:K08049] [EC:4.6.1.1]
101145463  CDKN2A; cyclin-dependent kinase inhibitor 2A isoform X1 [KO:K06621]
101145508  NFE2L2; nuclear factor erythroid 2-related factor 2 isoform X1 [KO:K05638]
101145572  EGLN2; prolyl hydroxylase EGLN2 [KO:K09592] [EC:1.14.11.29]
101145729  JUN; transcription factor Jun [KO:K04448]
101145841  IKBKG; NF-kappa-B essential modulator isoform X1 [KO:K07210]
101145851  SLC2A1; solute carrier family 2, facilitated glucose transporter member 1 [KO:K07299]
101145989  [KO:K03096]
101146009  FZD5; frizzled-5 [KO:K02375]
101146042  DVL2; segment polarity protein dishevelled homolog DVL-2 isoform X1 [KO:K02353]
101146090  CDKN2B; cyclin-dependent kinase 4 inhibitor B [KO:K04685]
101146129  [KO:K08738]
101146131  TGFBR2; TGF-beta receptor type-2 isoform X2 [KO:K04388] [EC:2.7.11.30]
101146209  CTNNA3; catenin alpha-3 isoform X2 [KO:K05691]
101146214  GSTO1; glutathione S-transferase omega-1 isoform X1 [KO:K00799] [EC:2.5.1.18]
101146234  IL5RA; interleukin-5 receptor subunit alpha [KO:K05067]
101146237  WNT7A; protein Wnt-7a [KO:K00572]
101146312  FGF16; fibroblast growth factor 16 [KO:K04358]
101146347  IL23A; interleukin-23 subunit alpha isoform X1 [KO:K05426]
101146434  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X2 [KO:K00922] [EC:2.7.1.153]
101146471  ETS1; protein C-ets-1 isoform X3 [KO:K02678]
101146479  ITGA6; integrin alpha-6 isoform X2 [KO:K06485]
101146562  NRAS; GTPase NRas [KO:K07828]
101146603  GNB4; guanine nucleotide-binding protein subunit beta-4 [KO:K04538]
101146642  LAMA4; laminin subunit alpha-4 isoform X1 [KO:K06241]
101146681  PTGS2; prostaglandin G/H synthase 2 [KO:K11987] [EC:1.14.99.1]
101146695  STAT2; signal transducer and activator of transcription 2 isoform X1 [KO:K11221]
101146783  GADD45A; growth arrest and DNA damage-inducible protein GADD45 alpha [KO:K04402]
101146886  [KO:K00799] [EC:2.5.1.18]
101146888  SHH; sonic hedgehog protein [KO:K11988]
101147042  GSTO2; glutathione S-transferase omega-2 [KO:K00799] [EC:2.5.1.18]
101147065  CDK4; cyclin-dependent kinase 4 isoform X1 [KO:K02089] [EC:2.7.11.22]
101147102  MMP2; 72 kDa type IV collagenase [KO:K01398] [EC:3.4.24.24]
101147168  LAMB3; laminin subunit beta-3 [KO:K06244]
101147170  WNT9A; protein Wnt-9a [KO:K01064]
101147171  EGLN1; egl nine homolog 1 isoform X1 [KO:K09592] [EC:1.14.11.29]
101147243  GNA12; guanine nucleotide-binding protein subunit alpha-12 isoform X1 [KO:K04346]
101147526  PTEN; phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN isoform X1 [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
101147579  ITGA3; integrin alpha-3 isoform X1 [KO:K06482]
101147630  PTCH2; protein patched homolog 2 isoform X1 [KO:K11101]
101147632  GNG12; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 isoform X2 [KO:K04347]
101147649  RASGRP3; ras guanyl-releasing protein 3 isoform X1 [KO:K12362]
101147653  CDKN1B; cyclin-dependent kinase inhibitor 1B [KO:K06624]
101147760  CASP7; LOW QUALITY PROTEIN: caspase-7 [KO:K04397] [EC:3.4.22.60]
101147792  WNT5A; protein Wnt-5a isoform X2 [KO:K00444]
101147948  EPOR; erythropoietin receptor [KO:K05079]
101148010  [KO:K03094]
101148055  WNT8A; protein Wnt-8a isoform X3 [KO:K00714]
101148081  [KO:K00799] [EC:2.5.1.18]
101148094  DAPK1; death-associated protein kinase 1 isoform X1 [KO:K08803] [EC:2.7.11.1]
101148095  GNG10; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 [KO:K04545]
101148160  ELOB; elongin-B [KO:K03873]
101148194  CAMK2B; calcium/calmodulin-dependent protein kinase type II subunit beta isoform X8 [KO:K04515] [EC:2.7.11.17]
101148241  WNT3A; protein Wnt-3a [KO:K00312]
101148344  HEYL; hairy/enhancer-of-split related with YRPW motif-like protein isoform X1 [KO:K09091]
101148684  [KO:K00799] [EC:2.5.1.18]
101148690  FLT3LG; fms-related tyrosine kinase 3 ligand isoform X4 [KO:K05454]
101148740  MSH6; DNA mismatch repair protein Msh6 isoform X1 [KO:K08737]
101148812  [KO:K00799] [EC:2.5.1.18]
101148851  ITGAV; integrin alpha-V isoform X1 [KO:K06487]
101149028  RALBP1; RalA-binding protein 1 [KO:K08773]
101149097  BCL2L11; bcl-2-like protein 11 isoform X6 [KO:K16341]
101149351  VHL; von Hippel-Lindau disease tumor suppressor isoform X1 [KO:K03871]
101149355  COL4A2; collagen alpha-2(IV) chain [KO:K06237]
101149410  BMP2; bone morphogenetic protein 2 [KO:K21283]
101149427  JAK2; tyrosine-protein kinase JAK2 [KO:K04447] [EC:2.7.10.2]
101149474  CALM1; calmodulin-1 isoform X1 [KO:K02183]
101149508  RALA; ras-related protein Ral-A [KO:K07834]
101149517  [KO:K00799] [EC:2.5.1.18]
101149605  RARA; retinoic acid receptor alpha isoform X2 [KO:K08527]
101149632  [KO:K04635]
101149651  GNAQ; guanine nucleotide-binding protein G(q) subunit alpha [KO:K04634]
101149731  TCF7; transcription factor 7 isoform X1 [KO:K02620]
101149786  [KO:K20994]
101149905  F2; prothrombin [KO:K01313] [EC:3.4.21.5]
101149990  FGF21; fibroblast growth factor 21 [KO:K22429]
101150004  NKX3-1; homeobox protein Nkx-3.1 [KO:K09348]
101150029  TPM3; tropomyosin alpha-3 chain isoform X11 [KO:K09290]
101150178  GNAI2; guanine nucleotide-binding protein G(I) subunit alpha-2 isoform X1 [KO:K04630]
101150181  ADCY5; adenylate cyclase type 5 isoform X1 [KO:K08045] [EC:4.6.1.1]
101150227  IFNGR1; interferon gamma receptor 1 isoform X1 [KO:K05132]
101150285  RELA; transcription factor p65 isoform X1 [KO:K04735]
101150306  EGLN3; prolyl hydroxylase EGLN3 [KO:K09592] [EC:1.14.11.29]
101150555  AXIN1; axin-1 isoform X1 [KO:K02157]
101150577  PDGFRB; platelet-derived growth factor receptor beta isoform X1 [KO:K05089] [EC:2.7.10.1]
101150579  NOTCH4; neurogenic locus notch homolog protein 4 isoform X1 [KO:K20996]
101150616  LPAR4; lysophosphatidic acid receptor 4 [KO:K04275]
101150664  FZD7; frizzled-7 [KO:K02432]
101150673  PTGER2; prostaglandin E2 receptor EP2 subtype [KO:K04259]
101150677  IL12A; interleukin-12 subunit alpha isoform X1 [KO:K05406]
101150691  PRKCB; protein kinase C beta type isoform X1 [KO:K19662] [EC:2.7.11.13]
101150703  SKP1; S-phase kinase-associated protein 1 [KO:K03094]
101150763  ARHGEF12; rho guanine nucleotide exchange factor 12 isoform X1 [KO:K07532]
101151055  DAPK2; death-associated protein kinase 2 isoform X1 [KO:K08803] [EC:2.7.11.1]
101151113  CALML5; calmodulin-like protein 5 [KO:K02183]
101151128  BAD; bcl2-associated agonist of cell death [KO:K02158]
101151289  NQO1; NAD(P)H dehydrogenase [quinone] 1 isoform X2 [KO:K00355] [EC:1.6.5.2]
101151399  FOXO1; forkhead box protein O1 isoform X2 [KO:K07201]
101151469  PRKACG; cAMP-dependent protein kinase catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]
101151475  CALML3; calmodulin-like protein 3 [KO:K02183]
101151577  RBX1; E3 ubiquitin-protein ligase RBX1 isoform X1 [KO:K03868] [EC:2.3.2.32]
101151621  TCF7L1; transcription factor 7-like 1 [KO:K04490]
101151662  CSF1R; macrophage colony-stimulating factor 1 receptor [KO:K05090] [EC:2.7.10.1]
101151677  [KO:K00799] [EC:2.5.1.18]
101151687  IL6; interleukin-6 isoform X1 [KO:K05405]
101151728  SUFU; suppressor of fused homolog isoform X5 [KO:K06229]
101151755  IFNG; interferon gamma [KO:K04687]
101151959  HDAC1; histone deacetylase 1 isoform X1 [KO:K06067] [EC:3.5.1.98]
101151982  WNT5B; protein Wnt-5b isoform X1 [KO:K00444]
101152009  HHIP; hedgehog-interacting protein isoform X1 [KO:K06231]
101152026  MAPK9; mitogen-activated protein kinase 9 isoform X4 [KO:K04440] [EC:2.7.11.24]
101152035  [KO:K00799] [EC:2.5.1.18]
101152077  CUL2; cullin-2 isoform X1 [KO:K03870]
101152087  TRAF6; TNF receptor-associated factor 6 [KO:K03175] [EC:2.3.2.27]
101152123  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
101152154  [KO:K10131]
101152179  FGFR1; fibroblast growth factor receptor 1 isoform X1 [KO:K04362] [EC:2.7.10.1]
101152199  [KO:K03872]
101152255  JUP; junction plakoglobin isoform X1 [KO:K10056]
101152421  PIM2; serine/threonine-protein kinase pim-2 [KO:K08806] [EC:2.7.11.1]
101152441  FAS; tumor necrosis factor receptor superfamily member 6 isoform X2 [KO:K04390]
101152462  [KO:K08738]
101152623  PTGER4; prostaglandin E2 receptor EP4 subtype isoform X1 [KO:K04261]
101152643  [KO:K00799] [EC:2.5.1.18]
101152678  PLEKHG5; pleckstrin homology domain-containing family G member 5 isoform X1 [KO:K19464]
101152695  RXRG; retinoic acid receptor RXR-gamma isoform X2 [KO:K08526]
101152769  BAX; apoptosis regulator BAX isoform X3 [KO:K02159]
101152851  RPS6KA5; ribosomal protein S6 kinase alpha-5 isoform X1 [KO:K04445] [EC:2.7.11.1]
101152855  RAD51; DNA repair protein RAD51 homolog 1 isoform X1 [KO:K04482]
101152864  BIRC5; baculoviral IAP repeat-containing protein 5 isoform X1 [KO:K08731]
101152866  GNA13; guanine nucleotide-binding protein subunit alpha-13 isoform X1 [KO:K04639]
101153046  FGFR2; fibroblast growth factor receptor 2 isoform X5 [KO:K05093] [EC:2.7.10.1]
101153224  IL6ST; interleukin-6 receptor subunit beta isoform X1 [KO:K05060]
101153250  GLI3; transcriptional activator GLI3 isoform X2 [KO:K06230]
101153263  CCNE2; G1/S-specific cyclin-E2 [KO:K06626]
101153366  [KO:K00799] [EC:2.5.1.18]
101153383  EP300; histone acetyltransferase p300 isoform X2 [KO:K04498] [EC:2.3.1.48]
101153449  MAX; protein max isoform X1 [KO:K04453]
101153465  NFKB1; nuclear factor NF-kappa-B p105 subunit isoform X1 [KO:K02580]
101153594  CAMK2A; calcium/calmodulin-dependent protein kinase type II subunit alpha isoform X1 [KO:K04515] [EC:2.7.11.17]
101153595  SMAD4; mothers against decapentaplegic homolog 4 isoform X1 [KO:K04501]
101153613  PLCB1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 isoform X1 [KO:K05858] [EC:3.1.4.11]
101153651  FZD8; frizzled-8 [KO:K02375]
101153700  EGF; pro-epidermal growth factor isoform X2 [KO:K04357]
101153728  GSTA4; glutathione S-transferase A4 isoform X1 [KO:K00799] [EC:2.5.1.18]
101153772  GNG3; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3 [KO:K04540]
101154185  CRK; adapter molecule crk isoform X1 [KO:K04438]
101154194  ROCK1; rho-associated protein kinase 1 isoform X1 [KO:K04514] [EC:2.7.11.1]
101154299  AXIN2; axin-2 isoform X1 [KO:K04385]
101154310  SMAD2; mothers against decapentaplegic homolog 2 isoform X1 [KO:K04500]
101154323  PLCB4; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 isoform X2 [KO:K05858] [EC:3.1.4.11]
101154353  GNB1; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 [KO:K04536]
101154397  IGF1; insulin-like growth factor I isoform X4 [KO:K05459]
101154546  IGF1R; insulin-like growth factor 1 receptor isoform X1 [KO:K05087] [EC:2.7.10.1]
101154591  DLL1; delta-like protein 1 [KO:K06051]
101154597  GNAI1; guanine nucleotide-binding protein G(I) subunit alpha-1 isoform X1 [KO:K04630]
109023024  HDAC2; histone deacetylase 2 [KO:K06067] [EC:3.5.1.98]
109023045  GNAS; guanine nucleotide-binding protein G(s) subunit alpha isoform X2 [KO:K04632]
109023121  CDK6; cyclin-dependent kinase 6 [KO:K02091] [EC:2.7.11.22]
109023149  [KO:K08738]
109023336  [KO:K04545]
109024512  [KO:K00799] [EC:2.5.1.18]
109024942  NOTCH1; neurogenic locus notch homolog protein 1 isoform X1 [KO:K02599]
109025170  EPAS1; endothelial PAS domain-containing protein 1 isoform X2 [KO:K09095]
109025238  TCF7L2; transcription factor 7-like 2 isoform X6 [KO:K04491]
109025264  SMAD3; mothers against decapentaplegic homolog 3 isoform X2 [KO:K23605]
109025414  GNG2; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 isoform X1 [KO:K07826]
109025459  CUL1; cullin-1 [KO:K03347]
109025530  HSP90AA1; heat shock protein HSP 90-alpha [KO:K04079]
109025909  [KO:K08738]
109027180  [KO:K00799] [EC:2.5.1.18]
109027862  [KO:K04542]
109027898  [KO:K02219]
109027916  [KO:K08738]
109028453  [KO:K04545]
109028877  [KO:K02219]
109029337  [KO:K04079]
115931954  WNT7B; protein Wnt-7b isoform X2 [KO:K00572]
115932121  [KO:K07210]
115932158  [KO:K08738]
115933428  [KO:K08738]
115934984  [KO:K00799] [EC:2.5.1.18]
115935778  [KO:K08803] [EC:2.7.11.1]
115935827  [KO:K05414]
115935829  [KO:K05414]
115935831  [KO:K05414]
115935832  [KO:K05414]
115935833  [KO:K05414]
115935834  [KO:K05414]
115936218  [KO:K04542]
115936257  [KO:K04079]
129524102  HES5; transcription factor HES-5 isoform X1 [KO:K06055]
129524120  [KO:K08738]
129524967  FRAT1; proto-oncogene FRAT1 [KO:K03069]
129524968  FRAT2; GSK-3-binding protein FRAT2 [KO:K03096]
129525450  FGF19; fibroblast growth factor 19 [KO:K22603]
129525695  SP1; transcription factor Sp1 isoform X1 [KO:K04684]
129526136  [KO:K08738]
129526430  [KO:K04358]
129526436  [KO:K08738]
129526696  AKT1; RAC-alpha serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
129526772  [KO:K02219]
129527250  [KO:K08738]
129528583  CALM3; calmodulin-3 [KO:K02183]
129528587  GNG8; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8 [KO:K04544]
129528881  KEAP1; kelch-like ECH-associated protein 1 [KO:K10456]
129528907  PRKACA; cAMP-dependent protein kinase catalytic subunit alpha isoform X1 [KO:K04345] [EC:2.7.11.11]
129528931  JAK3; tyrosine-protein kinase JAK3 [KO:K11218] [EC:2.7.10.2]
129529998  IL2RG; cytokine receptor common subunit gamma [KO:K05070]
129530148  [KO:K05066]
129531713  [KO:K04635]
129531741  [KO:K07201]
129532488  DVL1; segment polarity protein dishevelled homolog DVL-1 isoform X1 [KO:K02353]
129532589  CALML6; calmodulin-like protein 6 isoform X1 [KO:K02183]
129533700  E2F2; transcription factor E2F2 isoform X1 [KO:K09389]
129533953  RAC3; ras-related C3 botulinum toxin substrate 3 isoform X1 [KO:K07861]
134756931  [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
134756937  [KO:K05414]
Compound
C00027  Hydrogen peroxide
C00039  DNA
C00076  Calcium cation
C00122  Fumarate
C00149  (S)-Malate
C00165  Diacylglycerol
C00187  Cholesterol
C00280  Androstenedione
C00410  Progesterone
C00416  Phosphatidate
C00533  Nitric oxide
C00535  Testosterone
C00575  3',5'-Cyclic AMP
C00584  Prostaglandin E2
C00681  1-Acyl-sn-glycerol 3-phosphate
C00704  Superoxide
C00735  Cortisol
C00762  Cortisone
C00777  Retinoate
C00951  Estradiol-17beta
C01227  Dehydroepiandrosterone
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01471  Acrolein
C03917  Dihydrotestosterone
C05981  Phosphatidylinositol-3,4,5-trisphosphate
C07653  Flutamide
C15493  9-cis-Retinoic acid
C16038  2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
C16844  Hydroxyl radical
C21641  Hydroperoxyl radical
C21642  4-Hydroxynonenal
Reference
  Authors
Weinberg RA.
  Title
The biology of cancer
  Journal
Garland Science, Taylor & Francis Group, LLC (2007)
Reference
PMID:10647931
  Authors
Hanahan D, Weinberg RA
  Title
The hallmarks of cancer.
  Journal
Cell 100:57-70 (2000)
DOI:10.1016/S0092-8674(00)81683-9
Reference
PMID:15000146
  Authors
Grady WM.
  Title
Genomic instability and colon cancer.
  Journal
Cancer Metastasis Rev 23:11-27 (2004)
DOI:10.1023/A:1025861527711
Reference
PMID:16555243
  Authors
Soreide K, Janssen EA, Soiland H, Korner H, Baak JP.
  Title
Microsatellite instability in colorectal cancer.
  Journal
Br J Surg 93:395-406 (2006)
DOI:10.1002/bjs.5328
Reference
PMID:11078609
  Authors
Anwar S, Hall C, White J, Deakin M, Farrell W, Elder JB.
  Title
Hereditary non-polyposis colorectal cancer: an updated review.
  Journal
Eur J Surg Oncol 26:635-45 (2000)
DOI:10.1053/ejso.2000.0974
Reference
PMID:16699851
  Authors
Takayama T, Miyanishi K, Hayashi T, Sato Y, Niitsu Y.
  Title
Colorectal cancer: genetics of development and metastasis.
  Journal
J Gastroenterol 41:185-92 (2006)
DOI:10.1007/s00535-006-1801-6
Reference
PMID:12621137
  Authors
Lynch HT, de la Chapelle A.
  Title
Hereditary colorectal cancer.
  Journal
N Engl J Med 348:919-32 (2003)
DOI:10.1056/NEJMra012242
Reference
PMID:12951588
  Authors
Rajagopalan H, Nowak MA, Vogelstein B, Lengauer C.
  Title
The significance of unstable chromosomes in colorectal cancer.
  Journal
Nat Rev Cancer 3:695-701 (2003)
DOI:10.1038/nrc1165
Reference
PMID:10505543
  Authors
Behrens J.
  Title
Cadherins and catenins: role in signal transduction and tumor progression.
  Journal
Cancer Metastasis Rev 18:15-30 (1999)
DOI:10.1023/A:1006200102166
Reference
PMID:16042571
  Authors
Behrens J.
  Title
The role of the Wnt signalling pathway in colorectal tumorigenesis.
  Journal
Biochem Soc Trans 33:672-5 (2005)
DOI:10.1042/BST0330672
Reference
PMID:15349822
  Authors
Behrens J, Lustig B.
  Title
The Wnt connection to tumorigenesis.
  Journal
Int J Dev Biol 48:477-87 (2004)
DOI:10.1387/ijdb.041815jb
Reference
PMID:9196022
  Authors
Polakis P.
  Title
The adenomatous polyposis coli (APC) tumor suppressor.
  Journal
Biochim Biophys Acta 1332:F127-47 (1997)
DOI:10.1016/S0304-419X(97)00008-5
Reference
PMID:12737309
  Authors
Janssen KP.
  Title
Murine models of colorectal cancer: studying the role of oncogenic K-ras.
  Journal
Cell Mol Life Sci 60:495-506 (2003)
DOI:10.1007/s000180300041
Reference
PMID:11459867
  Authors
Adjei AA.
  Title
Blocking oncogenic Ras signaling for cancer therapy.
  Journal
J Natl Cancer Inst 93:1062-74 (2001)
DOI:10.1093/jnci/93.14.1062
Reference
PMID:15573119
  Authors
Arakawa H.
  Title
Netrin-1 and its receptors in tumorigenesis.
  Journal
Nat Rev Cancer 4:978-87 (2004)
DOI:10.1038/nrc1504
Reference
PMID:15310786
  Authors
Mehlen P, Fearon ER.
  Title
Role of the dependence receptor DCC in colorectal cancer pathogenesis.
  Journal
J Clin Oncol 22:3420-8 (2004)
DOI:10.1200/JCO.2004.02.019
Reference
PMID:11223406
  Authors
Peltomaki P.
  Title
DNA mismatch repair and cancer.
  Journal
Mutat Res 488:77-85 (2001)
DOI:10.1016/S1383-5742(00)00058-2
Reference
PMID:15711891
  Authors
Li F, Cao Y, Townsend CM Jr, Ko TC.
  Title
TGF-beta signaling in colon cancer cells.
  Journal
World J Surg 29:306-11 (2005)
DOI:10.1007/s00268-004-7813-6
Reference
PMID:11170304
  Authors
Roman C, Saha D, Beauchamp R.
  Title
TGF-beta and colorectal carcinogenesis.
  Journal
Microsc Res Tech 52:450-7 (2001)
DOI:10.1002/1097-0029(20010215)52:4<450::AID-JEMT1030>3.0.CO;2-O
Reference
PMID:16326109
  Authors
Watson AJ.
  Title
An overview of apoptosis and the prevention of colorectal cancer.
  Journal
Crit Rev Oncol Hematol 57:107-21 (2006)
DOI:10.1016/j.critrevonc.2005.06.005
Reference
PMID:15479695
  Authors
Watson AJ.
  Title
Apoptosis and colorectal cancer.
  Journal
Gut 53:1701-9 (2004)
DOI:10.1136/gut.2004.052704
Reference
PMID:11477132
  Authors
Houlston RS.
  Title
What we could do now: molecular pathology of colorectal cancer.
  Journal
Mol Pathol 54:206-14 (2001)
DOI:10.1136/mp.54.4.206
Reference
  Authors
Von Hoff D, Evans D, Hruban R (ed).
  Title
Pancreatic cancer
  Journal
Jones and Bartlett publishers (2005)
Reference
  Authors
Niitsu Y, Yokota J (ed).
  Title
[Oncogenes and Tumor Suppressor Genes for Medical Oncologist] (In Japanese)
  Journal
Nankodo (1999)
Reference
PMID:12459728
  Authors
Bardeesy N, DePinho RA.
  Title
Pancreatic cancer biology and genetics.
  Journal
Nat Rev Cancer 2:897-909 (2002)
DOI:10.1038/nrc949
Reference
PMID:11407945
  Authors
Bardeesy N, Sharpless NE, DePinho RA, Merlino G.
  Title
The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model.
  Journal
Semin Cancer Biol 11:201-18 (2001)
DOI:10.1006/scbi.2000.0371
Reference
PMID:12946833
  Authors
Cowgill SM, Muscarella P.
  Title
The genetics of pancreatic cancer.
  Journal
Am J Surg 186:279-86 (2003)
DOI:10.1016/S0002-9610(03)00226-5
Reference
PMID:16702400
  Authors
Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA.
  Title
Genetics and biology of pancreatic ductal adenocarcinoma.
  Journal
Genes Dev 20:1218-49 (2006)
DOI:10.1101/gad.1415606
Reference
PMID:10740269
  Authors
Shields JM, Pruitt K, McFall A, Shaub A, Der CJ.
  Title
Understanding Ras: 'it ain't over 'til it's over'.
  Journal
Trends Cell Biol 10:147-54 (2000)
DOI:10.1016/S0962-8924(00)01740-2
Reference
PMID:12648469
  Authors
Holbro T, Civenni G, Hynes NE.
  Title
The ErbB receptors and their role in cancer progression.
  Journal
Exp Cell Res 284:99-110 (2003)
DOI:10.1016/S0014-4827(02)00099-X
Reference
PMID:14967450
  Authors
Marmor MD, Skaria KB, Yarden Y.
  Title
Signal transduction and oncogenesis by ErbB/HER receptors.
  Journal
Int J Radiat Oncol Biol Phys 58:903-13 (2004)
DOI:10.1016/j.ijrobp.2003.06.002
Reference
PMID:14586404
  Authors
DeArmond D, Brattain MG, Jessup JM, Kreisberg J, Malik S, Zhao S, Freeman JW.
  Title
Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines.
  Journal
Oncogene 22:7781-95 (2003)
DOI:10.1038/sj.onc.1206966
Reference
PMID:12545153
  Authors
Wei D, Le X, Zheng L, Wang L, Frey JA, Gao AC, Peng Z, Huang S, Xiong HQ, Abbruzzese JL, Xie K.
  Title
Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis.
  Journal
Oncogene 22:319-29 (2003)
DOI:10.1038/sj.onc.1206122
Reference
PMID:14580692
  Authors
Toyonaga T, Nakano K, Nagano M, Zhao G, Yamaguchi K, Kuroki S, Eguchi T, Chijiiwa K, Tsuneyoshi M, Tanaka M.
  Title
Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer.
  Journal
Cancer Lett 201:107-16 (2003)
DOI:10.1016/S0304-3835(03)00482-8
Reference
PMID:12079267
  Authors
Schmid RM.
  Title
Genetic basis of pancreatic cancer.
  Journal
Best Pract Res Clin Gastroenterol 16:421-33 (2002)
DOI:10.1053/bega.2002.0316
Reference
PMID:15774796
  Authors
Elliott RL, Blobe GC.
  Title
Role of transforming growth factor Beta in human cancer.
  Journal
J Clin Oncol 23:2078-93 (2005)
DOI:10.1200/JCO.2005.02.047
Reference
PMID:15823750
  Authors
Rudkin TM, Foulkes WD.
  Title
BRCA2: breaks, mistakes and failed separations.
  Journal
Trends Mol Med 11:145-8 (2005)
DOI:10.1016/j.molmed.2005.02.003
Reference
PMID:11707511
  Authors
Venkitaraman AR.
  Title
Functions of BRCA1 and BRCA2 in the biological response to DNA damage.
  Journal
J Cell Sci 114:3591-8 (2001)
Reference
PMID:15639402
  Authors
Soni D, King JA, Kaye AH, Hovens CM.
  Title
Genetics of glioblastoma multiforme: mitogenic signaling and cell cycle pathways converge.
  Journal
J Clin Neurosci 12:1-5 (2005)
DOI:10.1016/j.jocn.2004.04.001
Reference
PMID:12154354
  Authors
Zhu Y, Parada LF.
  Title
The molecular and genetic basis of neurological tumours.
  Journal
Nat Rev Cancer 2:616-26 (2002)
DOI:10.1038/nrc866
Reference
PMID:11253051
  Authors
Holland EC.
  Title
Gliomagenesis: genetic alterations and mouse models.
  Journal
Nat Rev Genet 2:120-9 (2001)
DOI:10.1038/35052535
Reference
PMID:16700615
  Authors
Bansal K, Liang ML, Rutka JT.
  Title
Molecular biology of human gliomas.
  Journal
Technol Cancer Res Treat 5:185-94 (2006)
DOI:10.1177/153303460600500302
Reference
  Authors
Tabuchi K (ed).
  Title
[Gliomas: Research and therapy] (In Japanese)
  Journal
Springer-Verlag Tokyo (2006)
Reference
PMID:12762887
  Authors
Kapoor GS, O'Rourke DM.
  Title
Mitogenic signaling cascades in glial tumors.
  Journal
Neurosurgery 52:1425-34; discussion 1434-5 (2003)
DOI:10.1227/01.NEU.0000065135.28143.39
Reference
PMID:16095998
  Authors
Hulleman E, Helin K.
  Title
Molecular mechanisms in gliomagenesis.
  Journal
Adv Cancer Res 94:1-27 (2005)
DOI:10.1016/S0065-230X(05)94001-3
Reference
PMID:11057895
  Authors
Schlessinger J.
  Title
Cell signaling by receptor tyrosine kinases.
  Journal
Cell 103:211-25 (2000)
DOI:10.1016/S0092-8674(00)00114-8
Reference
PMID:9643506
  Authors
Ng HK, Lam PY.
  Title
The molecular genetics of central nervous system tumors.
  Journal
Pathology 30:196-202 (1998)
DOI:10.1080/00313029800169236
Reference
PMID:12084351
  Authors
Knobbe CB, Merlo A, Reifenberger G.
  Title
Pten signaling in gliomas.
  Journal
Neuro-oncol 4:196-211 (2002)
DOI:10.1093/neuonc/4.3.196
Reference
PMID:16557281
  Authors
Kondo T, Ezzat S, Asa SL.
  Title
Pathogenetic mechanisms in thyroid follicular-cell neoplasia.
  Journal
Nat Rev Cancer 6:292-306 (2006)
DOI:10.1038/nrc1836
Reference
PMID:16551846
  Authors
Chiloeches A, Marais R.
  Title
Is BRAF the Achilles' Heel of thyroid cancer?
  Journal
Clin Cancer Res 12:1661-4 (2006)
DOI:10.1158/1078-0432.CCR-06-0051
Reference
PMID:16946003
  Authors
Reddi HV, McIver B, Grebe SK, Eberhardt NL
  Title
The paired box-8/peroxisome proliferator-activated receptor-gamma oncogene in thyroid tumorigenesis.
  Journal
Endocrinology 148:932-5 (2007)
DOI:10.1210/en.2006-0926
Reference
PMID:17062879
  Authors
Santoro M, Melillo RM, Fusco A.
  Title
RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture.
  Journal
Eur J Endocrinol 155:645-653 (2006)
DOI:10.1530/eje.1.02289
Reference
PMID:16242838
  Authors
Pierotti MA, Greco A.
  Title
Oncogenic rearrangements of the NTRK1/NGF receptor.
  Journal
Cancer Lett 232:90-8 (2006)
DOI:10.1016/j.canlet.2005.07.043
Reference
PMID:16189702
  Authors
Sobrinho-Simoes M, Preto A, Rocha AS, Castro P, Maximo V, Fonseca E, Soares P.
  Title
Molecular pathology of well-differentiated thyroid carcinomas.
  Journal
Virchows Arch 447:787-93 (2005)
DOI:10.1007/s00428-005-0065-5
Reference
PMID:11165748
  Authors
Gimm O.
  Title
Thyroid cancer.
  Journal
Cancer Lett 163:143-56 (2001)
DOI:10.1016/S0304-3835(00)00697-2
Reference
PMID:12094241
  Authors
Williams D.
  Title
Cancer after nuclear fallout: lessons from the Chernobyl accident.
  Journal
Nat Rev Cancer 2:543-9 (2002)
DOI:10.1038/nrc845
Reference
PMID:16236521
  Authors
Steffen B, Muller-Tidow C, Schwable J, Berdel WE, Serve H.
  Title
The molecular pathogenesis of acute myeloid leukemia.
  Journal
Crit Rev Oncol Hematol 56:195-221 (2005)
DOI:10.1016/j.critrevonc.2004.10.012
Reference
PMID:12563308
  Authors
Tenen DG.
  Title
Disruption of differentiation in human cancer: AML shows the way.
  Journal
Nat Rev Cancer 3:89-101 (2003)
DOI:10.1038/nrc989
Reference
PMID:16146838
  Authors
Choudhary C, Muller-Tidow C, Berdel WE, Serve H.
  Title
Signal transduction of oncogenic Flt3.
  Journal
Int J Hematol 82:93-9 (2005)
DOI:10.1532/IJH97.05090
Reference
PMID:12951584
  Authors
Stirewalt DL, Radich JP.
  Title
The role of FLT3 in haematopoietic malignancies.
  Journal
Nat Rev Cancer 3:650-65 (2003)
DOI:10.1038/nrc1169
Reference
PMID:16642045
  Authors
Martelli AM, Nyakern M, Tabellini G, Bortul R, Tazzari PL, Evangelisti C, Cocco L.
  Title
Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia.
  Journal
Leukemia 20:911-28 (2006)
DOI:10.1038/sj.leu.2404245
Reference
PMID:15625120
  Authors
Lennartsson J, Jelacic T, Linnekin D, Shivakrupa R.
  Title
Normal and oncogenic forms of the receptor tyrosine kinase kit.
  Journal
Stem Cells 23:16-43 (2005)
DOI:10.1634/stemcells.2004-0117
Reference
PMID:11721960
  Authors
Lorsbach RB, Downing JR.
  Title
The role of the AML1 transcription factor in leukemogenesis.
  Journal
Int J Hematol 74:258-65 (2001)
DOI:10.1007/BF02982058
Reference
PMID:12468433
  Authors
Mizuki M, Schwable J, Steur C, Choudhary C, Agrawal S, Sargin B, Steffen B, Matsumura I, Kanakura Y, Bohmer FD, Muller-Tidow C, Berdel WE, Serve H.
  Title
Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations.
  Journal
Blood 101:3164-73 (2003)
DOI:10.1182/blood-2002-06-1677
Reference
PMID:17554387
  Authors
Mikesch JH, Steffen B, Berdel WE, Serve H, Muller-Tidow C.
  Title
The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia.
  Journal
Leukemia 21:1638-47 (2007)
DOI:10.1038/sj.leu.2404732
Reference
PMID:16352814
  Authors
Mueller BU, Pabst T, Fos J, Petkovic V, Fey MF, Asou N, Buergi U, Tenen DG.
  Title
ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression.
  Journal
Blood 107:3330-8 (2006)
DOI:10.1182/blood-2005-07-3068
Reference
PMID:15719031
  Authors
Ren R.
  Title
Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia.
  Journal
Nat Rev Cancer 5:172-83 (2005)
DOI:10.1038/nrc1567
Reference
PMID:11071626
  Authors
Deininger MW, Goldman JM, Melo JV.
  Title
The molecular biology of chronic myeloid leukemia.
  Journal
Blood 96:3343-56 (2000)
Reference
PMID:14982876
  Authors
Calabretta B, Perrotti D.
  Title
The biology of CML blast crisis.
  Journal
Blood 103:4010-22 (2004)
DOI:10.1182/blood-2003-12-4111
Reference
PMID:10403855
  Authors
Faderl S, Talpaz M, Estrov Z, O'Brien S, Kurzrock R, Kantarjian HM.
  Title
The biology of chronic myeloid leukemia.
  Journal
N Engl J Med 341:164-72 (1999)
DOI:10.1056/NEJM199907153410306
Reference
PMID:15156182
  Authors
Mitani K.
  Title
Molecular mechanisms of leukemogenesis by AML1/EVI-1.
  Journal
Oncogene 23:4263-9 (2004)
DOI:10.1038/sj.onc.1207777
Reference
PMID:16484590
  Authors
Dong M, Blobe GC.
  Title
Role of transforming growth factor-beta in hematologic malignancies.
  Journal
Blood 107:4589-96 (2006)
DOI:10.1182/blood-2005-10-4169
Reference
PMID:9834202
  Authors
Kurokawa M, Mitani K, Imai Y, Ogawa S, Yazaki Y, Hirai H.
  Title
The t(3;21) fusion product, AML1/Evi-1, interacts with Smad3 and blocks transforming growth factor-beta-mediated growth inhibition of myeloid cells.
  Journal
Blood 92:4003-12 (1998)
Reference
PMID:12801837
  Authors
Brusa G, Benvenuti M, Mazzacurati L, Mancini M, Pattacini L, Martinelli G, Barbieri E, Greenberger JS, Baccarani M, Santucci MA.
  Title
p53 loss of function enhances genomic instability and accelerates clonal evolution of murine myeloid progenitors expressing the p(210)BCR-ABL tyrosine kinase.
  Journal
Haematologica 88:622-30 (2003)
Reference
PMID:11160144
  Authors
Baldwin AS.
  Title
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.
  Journal
J Clin Invest 107:241-6 (2001)
DOI:10.1172/JCI11991
Reference
PMID:12244301
  Authors
Shin I, Yakes FM, Rojo F, Shin NY, Bakin AV, Baselga J, Arteaga CL.
  Title
PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization.
  Journal
Nat Med 8:1145-52 (2002)
DOI:10.1038/nm759
Reference
PMID:15948971
  Authors
Tilli CM, Van Steensel MA, Krekels GA, Neumann HA, Ramaekers FC.
  Title
Molecular aetiology and pathogenesis of basal cell carcinoma.
  Journal
Br J Dermatol 152:1108-24 (2005)
DOI:10.1111/j.1365-2133.2005.06587.x
Reference
PMID:12588368
  Authors
Saldanha G, Fletcher A, Slater DN.
  Title
Basal cell carcinoma: a dermatopathological and molecular biological update.
  Journal
Br J Dermatol 148:195-202 (2003)
DOI:10.1046/j.1365-2133.2003.05151.x
Reference
PMID:15978322
  Authors
Daya-Grosjean L, Couve-Privat S.
  Title
Sonic hedgehog signaling in basal cell carcinomas.
  Journal
Cancer Lett 225:181-92 (2005)
DOI:10.1016/j.canlet.2004.10.003
Reference
PMID:15468170
  Authors
Tsai KY, Tsao H.
  Title
The genetics of skin cancer.
  Journal
Am J Med Genet C Semin Med Genet 131C:82-92 (2004)
DOI:10.1002/ajmg.c.30037
Reference
PMID:16881963
  Authors
Athar M, Tang X, Lee JL, Kopelovich L, Kim AL.
  Title
Hedgehog signalling in skin development and cancer.
  Journal
Exp Dermatol 15:667-77 (2006)
DOI:10.1111/j.1600-0625.2006.00473.x
Reference
PMID:16306523
  Authors
Rubin AI, Chen EH, Ratner D.
  Title
Basal-cell carcinoma.
  Journal
N Engl J Med 353:2262-9 (2005)
DOI:10.1056/NEJMra044151
Reference
PMID:11276000
  Authors
Saldanha G.
  Title
The Hedgehog signalling pathway and cancer.
  Journal
J Pathol 193:427-32 (2001)
DOI:10.1002/1096-9896(2000)9999:9999<::AID-PATH815>3.0.CO;2-N
Reference
PMID:15270885
  Authors
Saldanha G, Ghura V, Potter L, Fletcher A.
  Title
Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation.
  Journal
Br J Dermatol 151:157-64 (2004)
DOI:10.1111/j.1365-2133.2004.06048.x
Reference
PMID:14737121
  Authors
Pasca di Magliano M, Hebrok M.
  Title
Hedgehog signalling in cancer formation and maintenance.
  Journal
Nat Rev Cancer 3:903-11 (2003)
DOI:10.1038/nrc1229
Reference
PMID:15656799
  Authors
Reifenberger J, Wolter M, Knobbe CB, Kohler B, Schonicke A, Scharwachter C, Kumar K, Blaschke B, Ruzicka T, Reifenberger G.
  Title
Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas.
  Journal
Br J Dermatol 152:43-51 (2005)
DOI:10.1111/j.1365-2133.2005.06353.x
Reference
PMID:14556242
  Authors
Cohen MM Jr.
  Title
The hedgehog signaling network.
  Journal
Am J Med Genet A 123:5-28 (2003)
DOI:10.1002/ajmg.a.20495
Reference
PMID:11736900
  Authors
Yamazaki F, Aragane Y, Kawada A, Tezuka T.
  Title
Immunohistochemical detection for nuclear beta-catenin in sporadic basal cell carcinoma.
  Journal
Br J Dermatol 145:771-7 (2001)
DOI:10.1046/j.1365-2133.2001.04468.x
Reference
PMID:16054233
  Authors
Erb P, Ji J, Wernli M, Kump E, Glaser A, Buchner SA.
  Title
Role of apoptosis in basal cell and squamous cell carcinoma formation.
  Journal
Immunol Lett 100:68-72 (2005)
DOI:10.1016/j.imlet.2005.06.008
Reference
PMID:11130178
  Authors
Toftgard R.
  Title
Hedgehog signalling in cancer.
  Journal
Cell Mol Life Sci 57:1720-31 (2000)
DOI:10.1007/PL00000654
Reference
PMID:16822996
  Authors
Miller AJ, Mihm MC Jr.
  Title
Melanoma.
  Journal
N Engl J Med 355:51-65 (2006)
DOI:10.1056/NEJMra052166
Reference
PMID:12894244
  Authors
Chin L.
  Title
The genetics of malignant melanoma: lessons from mouse and man.
  Journal
Nat Rev Cancer 3:559-70 (2003)
DOI:10.1038/nrc1145
Reference
PMID:16750612
  Authors
Takata M, Saida T.
  Title
Genetic alterations in melanocytic tumors.
  Journal
J Dermatol Sci 43:1-10 (2006)
DOI:10.1016/j.jdermsci.2006.05.002
Reference
PMID:15841168
  Authors
Chudnovsky Y, Khavari PA, Adams AE.
  Title
Melanoma genetics and the development of rational therapeutics.
  Journal
J Clin Invest 115:813-24 (2005)
DOI:10.1172/JCI24808
Reference
PMID:16001050
  Authors
Merlino G.
  Title
Cancer biology: the weakest link?
  Journal
Nature 436:33-5 (2005)
DOI:10.1038/436033a
Reference
PMID:16001072
  Authors
Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S, Beroukhim R, Milner DA, Granter SR, Du J, Lee C, Wagner SN, Li C, Golub TR, Rimm DL, Meyerson ML, Fisher DE, Sellers WR.
  Title
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.
  Journal
Nature 436:117-22 (2005)
DOI:10.1038/nature03664
Reference
PMID:16899407
  Authors
Levy C, Khaled M, Fisher DE.
  Title
MITF: master regulator of melanocyte development and melanoma oncogene.
  Journal
Trends Mol Med 12:406-14 (2006)
DOI:10.1016/j.molmed.2006.07.008
Reference
PMID:15009714
  Authors
Tsao H, Goel V, Wu H, Yang G, Haluska FG.
  Title
Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.
  Journal
J Invest Dermatol 122:337-41 (2004)
DOI:10.1046/j.0022-202X.2004.22243.x
Reference
PMID:11224709
  Authors
Gruss C, Herlyn M.
  Title
Role of cadherins and matrixins in melanoma.
  Journal
Curr Opin Oncol 13:117-23 (2001)
DOI:10.1097/00001622-200103000-00006
Reference
PMID:15721476
  Authors
Thompson JF, Scolyer RA, Kefford RF.
  Title
Cutaneous melanoma.
  Journal
Lancet 365:687-701 (2005)
DOI:10.1016/S0140-6736(05)17951-3
Reference
PMID:14695152
  Authors
Omholt K, Platz A, Kanter L, Ringborg U, Hansson J.
  Title
NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression.
  Journal
Clin Cancer Res 9:6483-8 (2003)
Reference
PMID:15557758
  Authors
Hussein MR.
  Title
The TP53 tumor suppressor gene and melanoma tumorigenesis: is there a relationship?
  Journal
Tumour Biol 25:200-7 (2004)
DOI:10.1159/000081103
Reference
PMID:10843728
  Authors
Lazar-Molnar E, Hegyesi H, Toth S, Falus A.
  Title
Autocrine and paracrine regulation by cytokines and growth factors in melanoma.
  Journal
Cytokine 12:547-54 (2000)
DOI:10.1006/cyto.1999.0614
Reference
PMID:16339096
  Authors
Cohen HT, McGovern FJ.
  Title
Renal-cell carcinoma.
  Journal
N Engl J Med 353:2477-90 (2005)
DOI:10.1056/NEJMra043172
Reference
PMID:15122209
  Authors
Pavlovich CP, Schmidt LS.
  Title
Searching for the hereditary causes of renal-cell carcinoma.
  Journal
Nat Rev Cancer 4:381-93 (2004)
DOI:10.1038/nrc1364
Reference
PMID:14634372
  Authors
Linehan WM, Walther MM, Zbar B.
  Title
The genetic basis of cancer of the kidney.
  Journal
J Urol 170:2163-72 (2003)
DOI:10.1097/01.ju.0000096060.92397.ed
Reference
PMID:14685170
  Authors
Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF.
  Title
Met, metastasis, motility and more.
  Journal
Nat Rev Mol Cell Biol 4:915-25 (2003)
DOI:10.1038/nrm1261
Reference
PMID:15611513
  Authors
Kim WY, Kaelin WG.
  Title
Role of VHL gene mutation in human cancer.
  Journal
J Clin Oncol 22:4991-5004 (2004)
DOI:10.1200/JCO.2004.05.061
Reference
PMID:17211469
  Authors
Sudarshan S, Linehan WM, Neckers L.
  Title
HIF and fumarate hydratase in renal cancer.
  Journal
Br J Cancer 96:403-7 (2007)
DOI:10.1038/sj.bjc.6603547
Reference
PMID:17287871
  Authors
Sudarshan S, Pinto PA, Neckers L, Linehan WM.
  Title
Mechanisms of disease: hereditary leiomyomatosis and renal cell cancer--a distinct form of hereditary kidney cancer.
  Journal
Nat Clin Pract Urol 4:104-10 (2007)
DOI:10.1038/ncpuro0711
Reference
PMID:12351585
  Authors
Bodmer D, van den Hurk W, van Groningen JJ, Eleveld MJ, Martens GJ, Weterman MA, van Kessel AG.
  Title
Understanding familial and non-familial renal cell cancer.
  Journal
Hum Mol Genet 11:2489-98 (2002)
DOI:10.1093/hmg/11.20.2489
Reference
PMID:17158541
  Authors
Mitra AP, Datar RH, Cote RJ.
  Title
Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification.
  Journal
J Clin Oncol 24:5552-64 (2006)
DOI:10.1200/JCO.2006.08.2073
Reference
PMID:16474624
  Authors
Wolff EM, Liang G, Jones PA.
  Title
Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer.
  Journal
Nat Clin Pract Urol 2:502-10 (2005)
DOI:10.1038/ncpuro0318
Reference
PMID:16110317
  Authors
Wu XR.
  Title
Urothelial tumorigenesis: a tale of divergent pathways.
  Journal
Nat Rev Cancer 5:713-25 (2005)
DOI:10.1038/nrc1697
Reference
PMID:11103787
  Authors
Brown NS, Jones A, Fujiyama C, Harris AL, Bicknell R.
  Title
Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors.
  Journal
Cancer Res 60:6298-302 (2000)
Reference
PMID:12850530
  Authors
Bellmunt J, Hussain M, Dinney CP.
  Title
Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor family.
  Journal
Crit Rev Oncol Hematol 46 Suppl:S85-104 (2003)
DOI:10.1016/S1040-8428(03)00067-2
Reference
PMID:17149381
  Authors
Sugano K, Kakizoe T.
  Title
Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging.
  Journal
Nat Clin Pract Urol 3:642-52 (2006)
DOI:10.1038/ncpuro0649
Reference
PMID:15746962
  Authors
Dunn KL, Espino PS, Drobic B, He S, Davie JR.
  Title
The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling.
  Journal
Biochem Cell Biol 83:1-14 (2005)
DOI:10.1139/o04-121
Reference
PMID:15551095
  Authors
Williams SG, Stein JP.
  Title
Molecular pathways in bladder cancer.
  Journal
Urol Res 32:373-85 (2004)
DOI:10.1007/s00240-003-0345-y
Reference
PMID:12878745
  Authors
Nelson WG, De Marzo AM, Isaacs WB.
  Title
Prostate cancer.
  Journal
N Engl J Med 349:366-81 (2003)
DOI:10.1056/NEJMra021562
Reference
PMID:15724144
  Authors
Li L, Ittmann MM, Ayala G, Tsai MJ, Amato RJ, Wheeler TM, Miles BJ, Kadmon D, Thompson TC.
  Title
The emerging role of the PI3-K-Akt pathway in prostate cancer progression.
  Journal
Prostate Cancer Prostatic Dis 8:108-18 (2005)
DOI:10.1038/sj.pcan.4500776
Reference
PMID:16551847
  Authors
Pienta KJ, Bradley D.
  Title
Mechanisms underlying the development of androgen-independent prostate cancer.
  Journal
Clin Cancer Res 12:1665-71 (2006)
DOI:10.1158/1078-0432.CCR-06-0067
Reference
PMID:11900250
  Authors
Feldman BJ, Feldman D.
  Title
The development of androgen-independent prostate cancer.
  Journal
Nat Rev Cancer 1:34-45 (2001)
DOI:10.1038/35094009
Reference
PMID:15082523
  Authors
Heinlein CA, Chang C.
  Title
Androgen receptor in prostate cancer.
  Journal
Endocr Rev 25:276-308 (2004)
DOI:10.1210/er.2002-0032
Reference
PMID:9422516
  Authors
Koivisto P, Kolmer M, Visakorpi T, Kallioniemi OP.
  Title
Androgen receptor gene and hormonal therapy failure of prostate cancer.
  Journal
Am J Pathol 152:1-9 (1998)
Reference
PMID:10835690
  Authors
Zhao XY, Malloy PJ, Krishnan AV, Swami S, Navone NM, Peehl DM, Feldman D.
  Title
Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor.
  Journal
Nat Med 6:703-6 (2000)
DOI:10.1038/76287
Reference
PMID:10453277
  Authors
Macri E, Loda M.
  Title
Role of p27 in prostate carcinogenesis.
  Journal
Cancer Metastasis Rev 17:337-44 (1998)
DOI:10.1023/A:1006133620914
Reference
PMID:11750244
  Authors
Steers WD.
  Title
5alpha-reductase activity in the prostate.
  Journal
Urology 58:17-24; discussion 24 (2001)
DOI:10.1016/S0090-4295(01)01299-7
Reference
PMID:8069858
  Authors
Lin D, Meyer DJ, Ketterer B, Lang NP, Kadlubar FF.
  Title
Effects of human and rat glutathione S-transferases on the covalent DNA binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: a possible mechanism of organ specificity in their carcinogenesis.
  Journal
Cancer Res 54:4920-6 (1994)
Reference
PMID:11527574
  Authors
Grimes CA, Jope RS.
  Title
The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.
  Journal
Prog Neurobiol 65:391-426 (2001)
DOI:10.1016/S0301-0082(01)00011-9
Reference
PMID:15947972
  Authors
Ryan AJ, Susil B, Jobling TW, Oehler MK.
  Title
Endometrial cancer.
  Journal
Cell Tissue Res 322:53-61 (2005)
DOI:10.1007/s00441-005-1109-5
Reference
PMID:14747944
  Authors
Lax SF.
  Title
Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.
  Journal
Virchows Arch 444:213-23 (2004)
DOI:10.1007/s00428-003-0947-3
Reference
PMID:16508724
  Authors
Shiozawa T, Konishi I.
  Title
Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.
  Journal
Int J Clin Oncol 11:13-21 (2006)
DOI:10.1007/s10147-005-0546-1
Reference
PMID:17028294
  Authors
Hecht JL, Mutter GL.
  Title
Molecular and pathologic aspects of endometrial carcinogenesis.
  Journal
J Clin Oncol 24:4783-91 (2006)
DOI:10.1200/JCO.2006.06.7173
Reference
PMID:11431710
  Authors
Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J.
  Title
Molecular pathology of endometrial hyperplasia and carcinoma.
  Journal
Hum Pathol 32:569-77 (2001)
DOI:10.1053/hupa.2001.25929
Reference
PMID:15284264
  Authors
Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH.
  Title
Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.
  Journal
J Clin Oncol 22:3126-32 (2004)
DOI:10.1200/JCO.2004.11.154
Reference
PMID:7585656
  Authors
Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF.
  Title
Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.
  Journal
Cancer Res 55:5693-8 (1995)
Reference
PMID:16248975
  Authors
Kim D, Chung J.
  Title
Akt: versatile mediator of cell survival and beyond.
  Journal
J Biochem Mol Biol 35:106-15 (2002)
DOI:10.5483/bmbrep.2002.35.1.106
Reference
PMID:12711111
  Authors
Sanchez-Cespedes M.
  Title
Dissecting the genetic alterations involved in lung carcinogenesis.
  Journal
Lung Cancer 40:111-21 (2003)
DOI:10.1016/S0169-5002(03)00033-3
Reference
PMID:11720739
  Authors
Kaye FJ.
  Title
Molecular biology of lung cancer.
  Journal
Lung Cancer 34 Suppl 2:S35-41 (2001)
DOI:10.1016/S0169-5002(01)00342-7
Reference
PMID:12616528
  Authors
Shivapurkar N, Reddy J, Chaudhary PM, Gazdar AF.
  Title
Apoptosis and lung cancer: a review.
  Journal
J Cell Biochem 88:885-98 (2003)
DOI:10.1002/jcb.10440
Reference
PMID:11807782
  Authors
Sartorius UA, Krammer PH.
  Title
Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines.
  Journal
Int J Cancer 97:584-92 (2002)
DOI:10.1002/ijc.10096
Reference
PMID:16064138
  Authors
Adhikary S, Eilers M.
  Title
Transcriptional regulation and transformation by Myc proteins.
  Journal
Nat Rev Mol Cell Biol 6:635-45 (2005)
DOI:10.1038/nrm1703
Reference
PMID:11463388
  Authors
Spruck C, Strohmaier H, Watson M, Smith AP, Ryan A, Krek TW, Reed SI.
  Title
A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1.
  Journal
Mol Cell 7:639-50 (2001)
DOI:10.1016/S1097-2765(01)00210-6
Reference
PMID:15109562
  Authors
Buttery RC, Rintoul RC, Sethi T.
  Title
Small cell lung cancer: the importance of the extracellular matrix.
  Journal
Int J Biochem Cell Biol 36:1154-60 (2004)
DOI:10.1016/S1357-2725(03)00261-9
Reference
PMID:11559746
  Authors
Yamada KM, Araki M.
  Title
Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis.
  Journal
J Cell Sci 114:2375-82 (2001)
Reference
PMID:11905738
  Authors
Rintoul RC, Sethi T.
  Title
The role of extracellular matrix in small-cell lung cancer.
  Journal
Lancet Oncol 2:437-42 (2001)
DOI:10.1016/S1470-2045(00)00421-6
Reference
PMID:12243753
  Authors
Ekedahl J, Joseph B, Grigoriev MY, Muller M, Magnusson C, Lewensohn R, Zhivotovsky B.
  Title
Expression of inhibitor of apoptosis proteins in small- and non-small-cell lung carcinoma cells.
  Journal
Exp Cell Res 279:277-90 (2002)
DOI:10.1006/excr.2002.5608
Reference
PMID:12379883
  Authors
Osada H, Takahashi T.
  Title
Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.
  Journal
Oncogene 21:7421-34 (2002)
DOI:10.1038/sj.onc.1205802
Reference
PMID:12741677
  Authors
Yokota J, Nishioka M, Tani M, Kohno T.
  Title
Genetic alterations responsible for metastatic phenotypes of lung cancer cells.
  Journal
Clin Exp Metastasis 20:189-93 (2003)
DOI:10.1023/a:1022978932215
Reference
PMID:16870043
  Authors
Aviel-Ronen S, Blackhall FH, Shepherd FA, Tsao MS.
  Title
K-ras mutations in non-small-cell lung carcinoma: a review.
  Journal
Clin Lung Cancer 8:30-8 (2006)
DOI:10.3816/CLC.2006.n.030
Reference
PMID:15948711
  Authors
Pfeifer GP, Dammann R.
  Title
Methylation of the tumor suppressor gene RASSF1A in human tumors.
  Journal
Biochemistry (Mosc) 70:576-83 (2005)
DOI:10.1007/s10541-005-0151-y
Reference
PMID:11902573
  Authors
Altucci L, Gronemeyer H.
  Title
The promise of retinoids to fight against cancer.
  Journal
Nat Rev Cancer 1:181-93 (2001)
DOI:10.1038/35106036
Reference
PMID:10944551
  Authors
Virmani AK, Rathi A, Zochbauer-Muller S, Sacchi N, Fukuyama Y, Bryant D, Maitra A, Heda S, Fong KM, Thunnissen F, Minna JD, Gazdar AF.
  Title
Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas.
  Journal
J Natl Cancer Inst 92:1303-7 (2000)
DOI:10.1093/jnci/92.16.1303
Reference
PMID:12867060
  Authors
Hirsch FR, Scagliotti GV, Langer CJ, Varella-Garcia M, Franklin WA.
  Title
Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapies.
  Journal
Lung Cancer 41 Suppl 1:S29-42 (2003)
DOI:10.1016/S0169-5002(03)00137-5
Reference
PMID:16112428
  Authors
Panani AD, Roussos C.
  Title
Cytogenetic and molecular aspects of lung cancer.
  Journal
Cancer Lett 239:1-9 (2006)
DOI:10.1016/j.canlet.2005.06.030
Reference
PMID:12407699
  Authors
Mitsuuchi Y, Testa JR.
  Title
Cytogenetics and molecular genetics of lung cancer.
  Journal
Am J Med Genet 115:183-8 (2002)
DOI:10.1002/ajmg.10692
Reference
PMID:15942304
  Authors
Breuer RH, Postmus PE, Smit EF.
  Title
Molecular pathology of non-small-cell lung cancer.
  Journal
Respiration 72:313-30 (2005)
DOI:10.1159/000085376
Reference
PMID:11895903
  Authors
Piyathilake CJ, Frost AR, Manne U, Weiss H, Bell WC, Heimburger DC, Grizzle WE.
  Title
Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung.
  Journal
Clin Cancer Res 8:734-44 (2002)
Reference
PMID:16189154
  Authors
Awaya H, Takeshima Y, Furonaka O, Kohno N, Inai K.
  Title
Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lung.
  Journal
J Clin Pathol 58:1076-80 (2005)
DOI:10.1136/jcp.2004.025585
Reference
PMID:21193867
  Authors
Lappano R, Maggiolini M
  Title
G protein-coupled receptors: novel targets for drug discovery in cancer.
  Journal
Nat Rev Drug Discov 10:47-60 (2011)
DOI:10.1038/nrd3320
Reference
PMID:24508914
  Authors
O'Hayre M, Degese MS, Gutkind JS
  Title
Novel insights into G protein and G protein-coupled receptor signaling in cancer.
  Journal
Curr Opin Cell Biol 27:126-35 (2014)
DOI:10.1016/j.ceb.2014.01.005
Reference
PMID:17251915
  Authors
Dorsam RT, Gutkind JS
  Title
G-protein-coupled receptors and cancer.
  Journal
Nat Rev Cancer 7:79-94 (2007)
DOI:10.1038/nrc2069
Related
pathway
ggo03320  PPAR signaling pathway
ggo04010  MAPK signaling pathway
ggo04020  Calcium signaling pathway
ggo04024  cAMP signaling pathway
ggo04060  Cytokine-cytokine receptor interaction
ggo04066  HIF-1 signaling pathway
ggo04110  Cell cycle
ggo04115  p53 signaling pathway
ggo04150  mTOR signaling pathway
ggo04151  PI3K-Akt signaling pathway
ggo04210  Apoptosis
ggo04310  Wnt signaling pathway
ggo04330  Notch signaling pathway
ggo04340  Hedgehog signaling pathway
ggo04350  TGF-beta signaling pathway
ggo04370  VEGF signaling pathway
ggo04510  Focal adhesion
ggo04512  ECM-receptor interaction
ggo04520  Adherens junction
ggo04630  JAK-STAT signaling pathway
ggo04915  Estrogen signaling pathway
KO pathway
ko05200   

DBGET integrated database retrieval system